concizumab: Clinical Trials

2 trials of concizumab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow concizumab: new trials by email Literature Review of concizumab trials Research Report on concizumab

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Trial Evaluating Efficacy and Safety of Prophylactic Administration of Concizumab in Patients With Severe Haemophilia A Without Inhibitors
Concizumab, Turoctocog alfa - Haemostasis, Haemophilia A
Phase 2CompletedNovo Nordisk A/S362017-08-162021-11-16
A Trial Evaluating the Efficacy and Safety of Prophylactic Administration of Concizumab in Haemophilia A and B Patients With Inhibitors
Concizumab, Eptacog alfa - Congenital Bleeding Disorder, Haemophilia A With Inhibitors
Phase 2CompletedNovo Nordisk A/S262017-08-102021-10-22

Conditions studied

Hemophilia A (1)

Sponsors

Novo Nordisk A/S (2)

Countries

Italy (2)  ·  Japan (2)  ·  Spain (2)  ·  Sweden (2)  ·  Ukraine (2)  ·  United Kingdom (2)  ·  United States (2)  ·  Austria (1)  ·  Canada (1)  ·  Croatia (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)  ·  Israel (1)

Results publications

PMID 31444162, PMID 35290453

NIH funding

2016 (2)